Abstract:The breadth and depth of information collected at a population level by birth defects surveillance programs in the United States serve as an important data source to guide public health action. Collaborative efforts at the state and national levels can help harmonize data collection and increase utility of birth defects programs.
“…Surveillance programs may differ in the extent to which severity of a clinical manifestation or objective assessment are used as criteria for inclusion in their database. Case ascertainment can encompass a spectrum of activities, such as (a) relying on vital records or passive reports from a limited number of data sources to seeking information actively from all possible data sources; (b) seeking information on live births only to seeking information on live births, still births, and pregnancy terminations; and (c) collecting data on birth defects only during the first year of life to collecting data on children with birth defects up to or beyond 2 years of age (Mai et al, ; Mai, Correa, et al, ). Approaches to case classification can vary from being based on information available from administrative datasets only to being based on diagnoses available from medical records with confirmatory objective tests or evaluations by clinical geneticists or dysmorphologists.…”
Background
Using the National Birth Defects Prevention Network (NBDPN) annual data report, U.S. national prevalence estimates for major birth defects are developed based on birth cohort 2010–2014.
Methods
Data from 39 U.S. population‐based birth defects surveillance programs (16 active case‐finding, 10 passive case‐finding with case confirmation, and 13 passive without case confirmation) were used to calculate pooled prevalence estimates for major defects by case‐finding approach. Fourteen active case‐finding programs including at least live birth and stillbirth pregnancy outcomes monitoring approximately one million births annually were used to develop national prevalence estimates, adjusted for maternal race/ethnicity (for all conditions examined) and maternal age (trisomies and gastroschisis). These calculations used a similar methodology to the previous estimates to examine changes over time.
Results
The adjusted national birth prevalence estimates per 10,000 live births ranged from 0.62 for interrupted aortic arch to 16.87 for clubfoot, and 19.93 for the 12 critical congenital heart defects combined. While the birth prevalence of most birth defects studied remained relatively stable over 15 years, an increasing prevalence was observed for gastroschisis and Down syndrome. Additionally, the prevalence for atrioventricular septal defect, tetralogy of Fallot, omphalocele, and trisomy 18 increased in this period compared to the previous periods. Active case‐finding programs generally had higher prevalence rates for most defects examined, most notably for anencephaly, anophthalmia/microphthalmia, trisomy 13, and trisomy 18.
Conclusion
National estimates of birth defects prevalence provide data for monitoring trends and understanding the impact of these conditions. Increasing prevalence rates observed for selected conditions warrant further examination.
“…Surveillance programs may differ in the extent to which severity of a clinical manifestation or objective assessment are used as criteria for inclusion in their database. Case ascertainment can encompass a spectrum of activities, such as (a) relying on vital records or passive reports from a limited number of data sources to seeking information actively from all possible data sources; (b) seeking information on live births only to seeking information on live births, still births, and pregnancy terminations; and (c) collecting data on birth defects only during the first year of life to collecting data on children with birth defects up to or beyond 2 years of age (Mai et al, ; Mai, Correa, et al, ). Approaches to case classification can vary from being based on information available from administrative datasets only to being based on diagnoses available from medical records with confirmatory objective tests or evaluations by clinical geneticists or dysmorphologists.…”
Background
Using the National Birth Defects Prevention Network (NBDPN) annual data report, U.S. national prevalence estimates for major birth defects are developed based on birth cohort 2010–2014.
Methods
Data from 39 U.S. population‐based birth defects surveillance programs (16 active case‐finding, 10 passive case‐finding with case confirmation, and 13 passive without case confirmation) were used to calculate pooled prevalence estimates for major defects by case‐finding approach. Fourteen active case‐finding programs including at least live birth and stillbirth pregnancy outcomes monitoring approximately one million births annually were used to develop national prevalence estimates, adjusted for maternal race/ethnicity (for all conditions examined) and maternal age (trisomies and gastroschisis). These calculations used a similar methodology to the previous estimates to examine changes over time.
Results
The adjusted national birth prevalence estimates per 10,000 live births ranged from 0.62 for interrupted aortic arch to 16.87 for clubfoot, and 19.93 for the 12 critical congenital heart defects combined. While the birth prevalence of most birth defects studied remained relatively stable over 15 years, an increasing prevalence was observed for gastroschisis and Down syndrome. Additionally, the prevalence for atrioventricular septal defect, tetralogy of Fallot, omphalocele, and trisomy 18 increased in this period compared to the previous periods. Active case‐finding programs generally had higher prevalence rates for most defects examined, most notably for anencephaly, anophthalmia/microphthalmia, trisomy 13, and trisomy 18.
Conclusion
National estimates of birth defects prevalence provide data for monitoring trends and understanding the impact of these conditions. Increasing prevalence rates observed for selected conditions warrant further examination.
“…The ability of birth defects surveillance programs to capture cases from all pregnancy outcomes is important, but capturing this data can be challenging. Whereas most systems capture both live births and fetal deaths, only approximately 40% are able to capture terminations of pregnancy (Mai et al, ). For some conditions, the lack of other pregnancy outcomes can greatly affect data completeness.…”
“…10 In the United States, 43 states have a population-based surveillance system for birth defects, covering about 80% of live births. 29 In South America, in 1967, the Latin American Collaborative Study of Congenital Malformations (ECLAMC) was created to act as a research program for congenital anomalies and also as a system for epidemiological surveillance. The network currently consists of 35 hospitals in Chile, Argentina, Bolivia, Brazil, Peru, Venezuela and Colombia.…”
Objectives: to describe the prevalence of congenital malformations in live births in Recife, based on the relationship of birth and infant death data. Methods: a cross-sectional study with data from the Live Birth Information System (Sinasc) and Mortality (MIS) of residents in Recife-PE between 2013 and 2015. The deterministic linkage of deaths and live births (LB) with malformation and the prevalence rate were calculated. Results: 545 (95.1%) deaths and live births were matched. According to the Sinasc, the prevalence of congenital malformations was 10.4 per 1,000 LB. After the linkage, the rate was 12.4. Malformations of the musculoskeletal system (42.1%) among live births were high-lighted, as well as malformations of the circulatory system (35.3%) found in infant deaths. Conclusions: linkage increased the prevalence of congenital malformations in the studied cohort. This demonstrates the potential of this strategy for the monitoring of congenital malformations, which can be used to monitor infant death.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.